Hemodynamic Effects of Combination Therapy With Inhaled Nitric Oxide and Iloprost in Patients With Pulmonary Hypertension and Right Ventricular Dysfunction After High-Risk Cardiac Surgery

被引:37
作者
Antoniou, Theofani [1 ]
Koletsis, Efstratios N. [2 ]
Prokakis, Christos [2 ]
Rellia, Panagiota [1 ]
Thanopoulos, Apostolos [1 ]
Theodoraki, Kassiani [3 ]
Zarkalis, Dimitrios [4 ]
Sfyrakis, Petros [4 ]
机构
[1] Onassis Cardiac Surg Ctr, Dept Cardiac Anesthesiol, Athens, Greece
[2] Univ Patras, Sch Med, Dept Cardiothorac Surg, GR-26110 Patras, Greece
[3] Aretaieion Univ Hosp, Dept Anesthesiol 1, Athens, Greece
[4] Onassis Cardiac Surg Ctr, Div Cardiac Surg & Transplantat Serv 1, Athens, Greece
关键词
inhaled nitric oxide; iloprost; pulmonary hypertension; right ventricular dysfunction; tricuspid annular velocity; tricuspid annular plane systolic excursion; CARDIOPULMONARY BYPASS; VASCULAR-RESISTANCE; CLINICAL IMPORTANCE; SURGICAL PATIENTS; VALVE SURGERY; PROSTACYCLIN; TRIAL; MANAGEMENT; PATHOPHYSIOLOGY; RECIPIENTS;
D O I
10.1053/j.jvca.2012.07.020
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
Objective: The purpose of this study was to evaluate the hemodynamic effects of inhaled nitric oxide (NO) plus aerosolized iloprost in patients with pulmonary hypertension/right ventricular dysfunction after cardiac surgery. Design: A retrospective study. Setting: A single center. Participants: Eight consecutive patients with valve disease and postextracorporeal circulation (ECC) pulmonary hypertension/right ventricular dysfunction. Intervention: The continuous inhalation of nitric oxide (10 ppm) and iloprost, 10 mu g, in repeated doses. Measurements and Main Results: The hemodynamic profile was obtained before inhalation, during the administration of inhaled NO alone (prior and after iloprost), and after the first 2 doses of iloprost. Tricuspid annular velocity and tricuspid annular plane systolic excursion were estimated at baseline and before and after adding iloprost. At the end of the protocol, there were significant decreases in pulmonary vascular resistance (p < 0.001), the mean pulmonary arterial pressure (p < 0.001), and the mean pulmonary artery pressure/mean arterial pressure ratio (p = 0.006). Both tricuspid annular velocity (p < 0.001) and tricuspid annular plane systolic excursion (p < 0.001) increased. The cardiac index (p < 0.001) and venous blood oxygen saturation (p = 0.001) increased throughout the evaluation period. Each iloprost dose was associated with further decreases in pulmonary vascular resistances/pressure. By comparing data at the beginning of inhaled NO with those after the second dose of iloprost, the authors noticed decreases in pulmonary vascular resistances (p = 0.004) and the mean pulmonary artery pressure (p = 0.017) and rises in tricuspid annular velocity (p < 0.001) and tricuspid annular systolic plane systolic excursion (p < 0.001). Conclusions: Inhaled NO and iloprost significantly reduced pulmonary hypertension and contributed to the improvement in right ventricular function. Inhaled NO and iloprost have additive effects on pulmonary vasculature. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:459 / 466
页数:8
相关论文
共 36 条
[1]
Inhaled Nitric Oxide Plus Iloprost in the Setting of Post-Left Assist Device Right Heart Dysfunction [J].
Antoniou, Theofani ;
Prokakis, Christos ;
Athanasopoulos, Georgios ;
Thanopoulos, Apostolos ;
Rellia, Panagiota ;
Zarkalis, Dimitrios ;
Kogerakis, Nektarios ;
Koletsis, Efstratios N. ;
Bairaktaris, Andreas ;
Pelletier, Glenn J. .
ANNALS OF THORACIC SURGERY, 2012, 94 (03) :792-799
[2]
Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension [J].
Argenziano, M ;
Choudhri, AF ;
Moazami, N ;
Rose, EA ;
Smith, CR ;
Levin, HR ;
Smerling, AJ ;
Oz, MC .
ANNALS OF THORACIC SURGERY, 1998, 65 (02) :340-344
[3]
Rebound pulmonary hypertension after inhalation of nitric oxide [J].
Atz, AM ;
Adatia, I ;
Wessel, DL .
ANNALS OF THORACIC SURGERY, 1996, 62 (06) :1759-1764
[4]
Inhaled nitric oxide improves hemodynamics in patients with acute pulmonary hypertension after high-risk cardiac surgery [J].
Beck, JR ;
Mongero, LB ;
Kroslowitz, RM ;
Choudhri, AF ;
Chen, JM ;
DeRose, JJ ;
Argenziano, M ;
Smerling, AJ ;
Oz, MC .
PERFUSION-UK, 1999, 14 (01) :37-42
[5]
Low systemic vascular resistance after cardiopulmonary bypass: Incidence, etiology, and clinical importance [J].
Carrel, T ;
Engelberger, L ;
Mohacsi, P ;
Neidhart, P ;
Schmidli, J .
JOURNAL OF CARDIAC SURGERY, 2000, 15 (05) :347-353
[6]
Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin [J].
Della Rocca, G ;
Coccia, C ;
Pompei, L ;
Ruberto, F ;
Venuta, F ;
De Giacomo, T ;
Pietropaoli, P .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2001, 15 (02) :224-227
[7]
Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement [J].
Fattouch, K ;
Sbraga, F ;
Bianco, G ;
Speziale, G ;
Gucciardo, M ;
Sampognaro, R ;
Ruvolo, G .
JOURNAL OF CARDIAC SURGERY, 2005, 20 (02) :171-176
[8]
Management of pulmonary hypertension:: Physiological and pharmacological considerations for anesthesiologists [J].
Fischer, LG ;
Van Aken, H ;
Bürkle, H .
ANESTHESIA AND ANALGESIA, 2003, 96 (06) :1603-1616
[9]
Inhaled nitric oxide therapy in adults:: European expert recommendations [J].
Germann, P ;
Braschi, A ;
Della Rocca, G ;
Dinh-Xuan, AT ;
Falke, K ;
Frostell, C ;
Gustafsson, LE ;
Hervé, P ;
Jolliet, P ;
Kaisers, U ;
Litvan, H ;
Macrae, DJ ;
Maggiorini, M ;
Marczin, N ;
Mueller, B ;
Payen, D ;
Ranucci, M ;
Schranz, D ;
Zimmermann, R ;
Ullrich, R .
INTENSIVE CARE MEDICINE, 2005, 31 (08) :1029-1041
[10]
Nitric oxide and peroxynitrite-mediated pulmonary cell death [J].
Gow, AJ ;
Thom, SR ;
Ischiropoulos, H .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1998, 274 (01) :L112-L118